Harumi Nakazawa

Pharmacokinetics and Pharmacodynamics of AJW200, a Humanized Monoclonal Antibody to von Willebrand Factor, in Monkeys

Shunsuke Kageyama, Hiroshi Yamamoto, Harumi Nakazawa et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 85 citations

Immunology, Pharmacotherapy, Immunotherapy +22

Anti-Human vWF Monoclonal Antibody, AJvW-2 Fab, Inhibits Repetitive Coronary Artery Thrombosis without Bleeding Time Prolongation in Dogs

Shunsuke Kageyama, Hiroshi Yamamoto, Harumi Nakazawa et al. · Thrombosis Research · 2001 · 41 citations

Thrombosis, Cardiovascular Disease, Ajvw-2 Fab +10

Synthesis and Antiviral Activity of Novel Anti-VZV 5-Substituted Uracil Nucleosides with a Cyclopropane Sugar Moiety

Tomoyuki Onishi, Chika Mukai, Ryusuke Nakagawa et al. · Journal of Medicinal Chemistry · 1999 · 37 citations

Vzv Kawaguchi Strain, Medicinal Chemistry, -5-Halovinyluracil Derivatives +15

Antiherpesvirus Activities of (1′ <i>S</i> ,2′ <i>R</i> )-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture

Satoshi Iwayama, Nobukazu Ono, Yuko Ohmura et al. · Antimicrobial Agents and Chemotherapy · 1998 · 34 citations · Full text

Mode of Action of (1′ <i>S</i> ,2′ <i>R</i> )-9-{[1′,2′-Bis(hydroxymethyl) cycloprop-1′-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus

Nobukazu Ono, Satoshi Iwayama, Katsuya Suzuki et al. · Antimicrobial Agents and Chemotherapy · 1998 · 31 citations · Full text

Virus Structure, Molecular Virology, Neurovirology +14